nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP2C19—Glyburide—gestational diabetes	0.199	0.32	CbGbCtD
Haloperidol—CYP2C9—Glyburide—gestational diabetes	0.165	0.266	CbGbCtD
Haloperidol—ABCB1—Glyburide—gestational diabetes	0.161	0.258	CbGbCtD
Haloperidol—CYP3A4—Glyburide—gestational diabetes	0.0962	0.155	CbGbCtD
Haloperidol—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.0193	0.095	CcSEcCtD
Haloperidol—Inappropriate antidiuretic hormone secretion—Glyburide—gestational diabetes	0.0163	0.0802	CcSEcCtD
Haloperidol—Cholestasis—Glyburide—gestational diabetes	0.0125	0.0614	CcSEcCtD
Haloperidol—EBP—uterus—gestational diabetes	0.00969	0.0741	CbGeAlD
Haloperidol—Hepatic function abnormal—Glyburide—gestational diabetes	0.00787	0.0387	CcSEcCtD
Haloperidol—Visual disturbance—Glyburide—gestational diabetes	0.00726	0.0357	CcSEcCtD
Haloperidol—Hypoglycaemia—Glyburide—gestational diabetes	0.00705	0.0347	CcSEcCtD
Haloperidol—Hyponatraemia—Glyburide—gestational diabetes	0.00691	0.034	CcSEcCtD
Haloperidol—CBR1—islet of Langerhans—gestational diabetes	0.00677	0.0518	CbGeAlD
Haloperidol—Sweating increased—Glyburide—gestational diabetes	0.00579	0.0285	CcSEcCtD
Haloperidol—Pancytopenia—Glyburide—gestational diabetes	0.00565	0.0278	CcSEcCtD
Haloperidol—H1F0—islet of Langerhans—gestational diabetes	0.00555	0.0424	CbGeAlD
Haloperidol—Photosensitivity reaction—Glyburide—gestational diabetes	0.00543	0.0267	CcSEcCtD
Haloperidol—H1F0—embryo—gestational diabetes	0.00537	0.041	CbGeAlD
Haloperidol—Jaundice—Glyburide—gestational diabetes	0.00517	0.0254	CcSEcCtD
Haloperidol—Agranulocytosis—Glyburide—gestational diabetes	0.00495	0.0243	CcSEcCtD
Haloperidol—Hepatitis—Glyburide—gestational diabetes	0.00476	0.0234	CcSEcCtD
Haloperidol—Visual impairment—Glyburide—gestational diabetes	0.00459	0.0226	CcSEcCtD
Haloperidol—GRIN2B—head—gestational diabetes	0.00447	0.0342	CbGeAlD
Haloperidol—Eye disorder—Glyburide—gestational diabetes	0.00445	0.0219	CcSEcCtD
Haloperidol—CBR1—uterus—gestational diabetes	0.00442	0.0338	CbGeAlD
Haloperidol—CBR1—adipose tissue—gestational diabetes	0.00432	0.033	CbGeAlD
Haloperidol—Alopecia—Glyburide—gestational diabetes	0.00421	0.0207	CcSEcCtD
Haloperidol—Malnutrition—Glyburide—gestational diabetes	0.00414	0.0204	CcSEcCtD
Haloperidol—SIGMAR1—islet of Langerhans—gestational diabetes	0.00401	0.0306	CbGeAlD
Haloperidol—Vision blurred—Glyburide—gestational diabetes	0.0039	0.0192	CcSEcCtD
Haloperidol—Tremor—Glyburide—gestational diabetes	0.00388	0.0191	CcSEcCtD
Haloperidol—Anaemia—Glyburide—gestational diabetes	0.00383	0.0188	CcSEcCtD
Haloperidol—DRD3—head—gestational diabetes	0.00375	0.0287	CbGeAlD
Haloperidol—Leukopenia—Glyburide—gestational diabetes	0.00371	0.0182	CcSEcCtD
Haloperidol—H1F0—uterus—gestational diabetes	0.00362	0.0277	CbGeAlD
Haloperidol—CBR1—vagina—gestational diabetes	0.00359	0.0275	CbGeAlD
Haloperidol—Convulsion—Glyburide—gestational diabetes	0.00359	0.0177	CcSEcCtD
Haloperidol—H1F0—adipose tissue—gestational diabetes	0.00354	0.0271	CbGeAlD
Haloperidol—Confusional state—Glyburide—gestational diabetes	0.00341	0.0168	CcSEcCtD
Haloperidol—Oedema—Glyburide—gestational diabetes	0.00338	0.0166	CcSEcCtD
Haloperidol—CBR1—head—gestational diabetes	0.00332	0.0254	CbGeAlD
Haloperidol—Nervous system disorder—Glyburide—gestational diabetes	0.00332	0.0163	CcSEcCtD
Haloperidol—Thrombocytopenia—Glyburide—gestational diabetes	0.00331	0.0163	CcSEcCtD
Haloperidol—Hyperhidrosis—Glyburide—gestational diabetes	0.00327	0.0161	CcSEcCtD
Haloperidol—Anorexia—Glyburide—gestational diabetes	0.00322	0.0158	CcSEcCtD
Haloperidol—KCNH2—islet of Langerhans—gestational diabetes	0.00319	0.0244	CbGeAlD
Haloperidol—Hypotension—Glyburide—gestational diabetes	0.00316	0.0155	CcSEcCtD
Haloperidol—Dyspnoea—Glyburide—gestational diabetes	0.00301	0.0148	CcSEcCtD
Haloperidol—Dyspepsia—Glyburide—gestational diabetes	0.00298	0.0146	CcSEcCtD
Haloperidol—H1F0—vagina—gestational diabetes	0.00294	0.0225	CbGeAlD
Haloperidol—Decreased appetite—Glyburide—gestational diabetes	0.00294	0.0145	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00292	0.0144	CcSEcCtD
Haloperidol—Feeling abnormal—Glyburide—gestational diabetes	0.00279	0.0137	CcSEcCtD
Haloperidol—H1F0—head—gestational diabetes	0.00272	0.0208	CbGeAlD
Haloperidol—Urticaria—Glyburide—gestational diabetes	0.00269	0.0132	CcSEcCtD
Haloperidol—DRD1—head—gestational diabetes	0.00268	0.0205	CbGeAlD
Haloperidol—CYP3A5—islet of Langerhans—gestational diabetes	0.00263	0.0201	CbGeAlD
Haloperidol—SIGMAR1—uterus—gestational diabetes	0.00261	0.02	CbGeAlD
Haloperidol—HTR2B—uterus—gestational diabetes	0.00261	0.0199	CbGeAlD
Haloperidol—SIGMAR1—adipose tissue—gestational diabetes	0.00256	0.0195	CbGeAlD
Haloperidol—HTR2B—adipose tissue—gestational diabetes	0.00255	0.0195	CbGeAlD
Haloperidol—Hypersensitivity—Glyburide—gestational diabetes	0.00249	0.0123	CcSEcCtD
Haloperidol—Pruritus—Glyburide—gestational diabetes	0.00239	0.0118	CcSEcCtD
Haloperidol—Diarrhoea—Glyburide—gestational diabetes	0.00231	0.0114	CcSEcCtD
Haloperidol—HTR1B—head—gestational diabetes	0.00217	0.0166	CbGeAlD
Haloperidol—Vomiting—Glyburide—gestational diabetes	0.00215	0.0106	CcSEcCtD
Haloperidol—Rash—Glyburide—gestational diabetes	0.00213	0.0105	CcSEcCtD
Haloperidol—Dermatitis—Glyburide—gestational diabetes	0.00213	0.0105	CcSEcCtD
Haloperidol—SIGMAR1—vagina—gestational diabetes	0.00212	0.0162	CbGeAlD
Haloperidol—HTR2B—vagina—gestational diabetes	0.00212	0.0162	CbGeAlD
Haloperidol—Headache—Glyburide—gestational diabetes	0.00212	0.0104	CcSEcCtD
Haloperidol—HTR1D—head—gestational diabetes	0.0021	0.0161	CbGeAlD
Haloperidol—KCNH2—uterus—gestational diabetes	0.00208	0.0159	CbGeAlD
Haloperidol—HTR2A—embryo—gestational diabetes	0.00206	0.0158	CbGeAlD
Haloperidol—Nausea—Glyburide—gestational diabetes	0.00201	0.00988	CcSEcCtD
Haloperidol—HTR2B—head—gestational diabetes	0.00196	0.015	CbGeAlD
Haloperidol—CYP2C19—vagina—gestational diabetes	0.00177	0.0136	CbGeAlD
Haloperidol—CYP1A1—uterus—gestational diabetes	0.00176	0.0134	CbGeAlD
Haloperidol—CYP1A1—adipose tissue—gestational diabetes	0.00172	0.0131	CbGeAlD
Haloperidol—KCNH2—vagina—gestational diabetes	0.00169	0.0129	CbGeAlD
Haloperidol—CYP3A5—adipose tissue—gestational diabetes	0.00168	0.0128	CbGeAlD
Haloperidol—HRH1—adipose tissue—gestational diabetes	0.00163	0.0125	CbGeAlD
Haloperidol—DRD2—head—gestational diabetes	0.00159	0.0121	CbGeAlD
Haloperidol—KCNH2—head—gestational diabetes	0.00156	0.0119	CbGeAlD
Haloperidol—CYP1A1—vagina—gestational diabetes	0.00143	0.0109	CbGeAlD
Haloperidol—ABCB1—islet of Langerhans—gestational diabetes	0.0014	0.0107	CbGeAlD
Haloperidol—CYP3A5—vagina—gestational diabetes	0.0014	0.0107	CbGeAlD
Haloperidol—HRH1—vagina—gestational diabetes	0.00136	0.0104	CbGeAlD
Haloperidol—ABCB1—embryo—gestational diabetes	0.00135	0.0103	CbGeAlD
Haloperidol—CYP1A1—head—gestational diabetes	0.00132	0.0101	CbGeAlD
Haloperidol—HRH1—head—gestational diabetes	0.00125	0.00957	CbGeAlD
Haloperidol—HTR2A—vagina—gestational diabetes	0.00113	0.00865	CbGeAlD
Haloperidol—HTR2A—head—gestational diabetes	0.00105	0.00799	CbGeAlD
Haloperidol—CYP2D6—head—gestational diabetes	0.000953	0.00728	CbGeAlD
Haloperidol—ABCB1—uterus—gestational diabetes	0.000912	0.00698	CbGeAlD
Haloperidol—ABCB1—adipose tissue—gestational diabetes	0.000892	0.00682	CbGeAlD
Haloperidol—ABCB1—vagina—gestational diabetes	0.000742	0.00567	CbGeAlD
Haloperidol—ABCB1—head—gestational diabetes	0.000685	0.00524	CbGeAlD
Haloperidol—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000435	0.00975	CbGpPWpGaD
Haloperidol—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000435	0.00975	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—GGCT—gestational diabetes	0.000431	0.00966	CbGpPWpGaD
Haloperidol—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000417	0.00936	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—MTNR1B—gestational diabetes	0.0004	0.00896	CbGpPWpGaD
Haloperidol—EBP—Metabolism—GLS2—gestational diabetes	0.000383	0.00858	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—GLS2—gestational diabetes	0.000377	0.00844	CbGpPWpGaD
Haloperidol—KCNH2—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000373	0.00836	CbGpPWpGaD
Haloperidol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000372	0.00834	CbGpPWpGaD
Haloperidol—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000367	0.00823	CbGpPWpGaD
Haloperidol—HTR1D—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000366	0.0082	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—MTNR1B—gestational diabetes	0.00036	0.00806	CbGpPWpGaD
Haloperidol—HTR1B—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000358	0.00803	CbGpPWpGaD
Haloperidol—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000356	0.00798	CbGpPWpGaD
Haloperidol—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000356	0.00798	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000355	0.00795	CbGpPWpGaD
Haloperidol—DRD4—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000353	0.0079	CbGpPWpGaD
Haloperidol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000352	0.00788	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—NAMPT—gestational diabetes	0.000349	0.00783	CbGpPWpGaD
Haloperidol—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000347	0.00778	CbGpPWpGaD
Haloperidol—EBP—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000342	0.00767	CbGpPWpGaD
Haloperidol—HTR1D—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00034	0.00761	CbGpPWpGaD
Haloperidol—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000337	0.00754	CbGpPWpGaD
Haloperidol—HTR1B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000332	0.00745	CbGpPWpGaD
Haloperidol—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000327	0.00734	CbGpPWpGaD
Haloperidol—DRD4—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000327	0.00733	CbGpPWpGaD
Haloperidol—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000325	0.00728	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—NAMPT—gestational diabetes	0.000314	0.00705	CbGpPWpGaD
Haloperidol—DRD3—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000313	0.00702	CbGpPWpGaD
Haloperidol—HTR2B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000312	0.007	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—NAMPT—gestational diabetes	0.00031	0.00695	CbGpPWpGaD
Haloperidol—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000302	0.00676	CbGpPWpGaD
Haloperidol—DRD1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000295	0.0066	CbGpPWpGaD
Haloperidol—HTR1D—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000291	0.00652	CbGpPWpGaD
Haloperidol—DRD3—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000291	0.00651	CbGpPWpGaD
Haloperidol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000288	0.00645	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000286	0.00641	CbGpPWpGaD
Haloperidol—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000285	0.00639	CbGpPWpGaD
Haloperidol—HTR1B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000285	0.00639	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000284	0.00637	CbGpPWpGaD
Haloperidol—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000284	0.00636	CbGpPWpGaD
Haloperidol—DRD4—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00028	0.00628	CbGpPWpGaD
Haloperidol—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000277	0.00622	CbGpPWpGaD
Haloperidol—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000277	0.00622	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000272	0.00609	CbGpPWpGaD
Haloperidol—HTR2B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000268	0.006	CbGpPWpGaD
Haloperidol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000265	0.00593	CbGpPWpGaD
Haloperidol—UGT1A9—Biological oxidations—CYP19A1—gestational diabetes	0.000264	0.00591	CbGpPWpGaD
Haloperidol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000262	0.00588	CbGpPWpGaD
Haloperidol—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000261	0.00585	CbGpPWpGaD
Haloperidol—UGT1A9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00026	0.00583	CbGpPWpGaD
Haloperidol—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000259	0.0058	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000257	0.00577	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000254	0.00569	CbGpPWpGaD
Haloperidol—DRD1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000252	0.00566	CbGpPWpGaD
Haloperidol—GRIN2B—Alzheimers Disease—TNF—gestational diabetes	0.00025	0.00561	CbGpPWpGaD
Haloperidol—DRD3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000249	0.00558	CbGpPWpGaD
Haloperidol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000245	0.00549	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—GCK—gestational diabetes	0.000244	0.00547	CbGpPWpGaD
Haloperidol—DRD2—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00024	0.00537	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—NAMPT—gestational diabetes	0.000237	0.00532	CbGpPWpGaD
Haloperidol—H1F0—Apoptosis—TNF—gestational diabetes	0.000236	0.00528	CbGpPWpGaD
Haloperidol—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000233	0.00523	CbGpPWpGaD
Haloperidol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000224	0.00503	CbGpPWpGaD
Haloperidol—DRD2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000222	0.00499	CbGpPWpGaD
Haloperidol—CYP3A7—Biological oxidations—CYP19A1—gestational diabetes	0.000222	0.00497	CbGpPWpGaD
Haloperidol—HTR1D—GPCR ligand binding—MTNR1B—gestational diabetes	0.000222	0.00497	CbGpPWpGaD
Haloperidol—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000221	0.00496	CbGpPWpGaD
Haloperidol—HTR2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000219	0.00491	CbGpPWpGaD
Haloperidol—CYP3A7—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000219	0.0049	CbGpPWpGaD
Haloperidol—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000218	0.00489	CbGpPWpGaD
Haloperidol—HTR1B—GPCR ligand binding—MTNR1B—gestational diabetes	0.000217	0.00486	CbGpPWpGaD
Haloperidol—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000215	0.00481	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000214	0.0048	CbGpPWpGaD
Haloperidol—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000214	0.0048	CbGpPWpGaD
Haloperidol—DRD4—GPCR ligand binding—MTNR1B—gestational diabetes	0.000213	0.00479	CbGpPWpGaD
Haloperidol—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000213	0.00477	CbGpPWpGaD
Haloperidol—EBP—Metabolism—NAMPT—gestational diabetes	0.00021	0.0047	CbGpPWpGaD
Haloperidol—EBP—Metabolism—GCK—gestational diabetes	0.000208	0.00467	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—NAMPT—gestational diabetes	0.000206	0.00462	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—GCK—gestational diabetes	0.000205	0.0046	CbGpPWpGaD
Haloperidol—HTR2B—GPCR ligand binding—MTNR1B—gestational diabetes	0.000204	0.00457	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000202	0.00453	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—ADIPOQ—gestational diabetes	0.000201	0.00451	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000194	0.00435	CbGpPWpGaD
Haloperidol—DRD1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000192	0.00431	CbGpPWpGaD
Haloperidol—DRD2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000191	0.00427	CbGpPWpGaD
Haloperidol—DRD3—GPCR ligand binding—MTNR1B—gestational diabetes	0.00019	0.00425	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000187	0.0042	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000187	0.00419	CbGpPWpGaD
Haloperidol—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000182	0.00408	CbGpPWpGaD
Haloperidol—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000182	0.00407	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—LEP—gestational diabetes	0.000178	0.00398	CbGpPWpGaD
Haloperidol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000173	0.00388	CbGpPWpGaD
Haloperidol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000171	0.00383	CbGpPWpGaD
Haloperidol—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.00016	0.00359	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—LEP—gestational diabetes	0.00016	0.00358	CbGpPWpGaD
Haloperidol—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000158	0.00354	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—LEP—gestational diabetes	0.000158	0.00353	CbGpPWpGaD
Haloperidol—EBP—Metabolism—CYP19A1—gestational diabetes	0.000152	0.00342	CbGpPWpGaD
Haloperidol—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000151	0.00339	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—CYP19A1—gestational diabetes	0.00015	0.00336	CbGpPWpGaD
Haloperidol—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000149	0.00335	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—MTNR1B—gestational diabetes	0.000145	0.00325	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—MTNR1B—gestational diabetes	0.000143	0.0032	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—MTNR1B—gestational diabetes	0.000142	0.00319	CbGpPWpGaD
Haloperidol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000141	0.00315	CbGpPWpGaD
Haloperidol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000141	0.00315	CbGpPWpGaD
Haloperidol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00014	0.00314	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GGCT—gestational diabetes	0.00013	0.0029	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000125	0.00281	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—LEP—gestational diabetes	0.000125	0.0028	CbGpPWpGaD
Haloperidol—KCNH2—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000124	0.00278	CbGpPWpGaD
Haloperidol—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000124	0.00278	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000123	0.00275	CbGpPWpGaD
Haloperidol—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000122	0.00274	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—LEP—gestational diabetes	0.000121	0.0027	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000121	0.0027	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000115	0.00258	CbGpPWpGaD
Haloperidol—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000114	0.00255	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—MTNR1B—gestational diabetes	0.000114	0.00255	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GLS2—gestational diabetes	0.000113	0.00254	CbGpPWpGaD
Haloperidol—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000113	0.00253	CbGpPWpGaD
Haloperidol—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000112	0.00252	CbGpPWpGaD
Haloperidol—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000111	0.0025	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000111	0.0025	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—MTNR1B—gestational diabetes	0.00011	0.00246	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GGCT—gestational diabetes	0.000109	0.00244	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000109	0.00243	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000108	0.00242	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000107	0.0024	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000105	0.00234	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000101	0.00227	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—MTNR1B—gestational diabetes	9.86e-05	0.00221	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—MTNR1B—gestational diabetes	9.73e-05	0.00218	CbGpPWpGaD
Haloperidol—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	9.65e-05	0.00216	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GLS2—gestational diabetes	9.52e-05	0.00213	CbGpPWpGaD
Haloperidol—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	9.52e-05	0.00213	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—FGF2—gestational diabetes	9.48e-05	0.00213	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	8.97e-05	0.00201	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.97e-05	0.00201	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—LEPR—gestational diabetes	8.5e-05	0.0019	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—LEPR—gestational diabetes	8.32e-05	0.00186	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—MTNR1B—gestational diabetes	8.2e-05	0.00184	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—LEPR—gestational diabetes	8.19e-05	0.00184	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—MTNR1B—gestational diabetes	8.07e-05	0.00181	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—MTNR1B—gestational diabetes	8.05e-05	0.0018	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GGCT—gestational diabetes	7.88e-05	0.00177	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—LEPR—gestational diabetes	7.82e-05	0.00175	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	7.45e-05	0.00167	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—MTNR1B—gestational diabetes	7.45e-05	0.00167	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GGCT—gestational diabetes	7.44e-05	0.00167	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—LEPR—gestational diabetes	7.37e-05	0.00165	CbGpPWpGaD
Haloperidol—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	7.35e-05	0.00165	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—MTNR1B—gestational diabetes	7.33e-05	0.00164	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—MTNR1B—gestational diabetes	7.31e-05	0.00164	CbGpPWpGaD
Haloperidol—ABCB1—Allograft Rejection—TNF—gestational diabetes	7.29e-05	0.00163	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—LEPR—gestational diabetes	7.27e-05	0.00163	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GLS2—gestational diabetes	6.88e-05	0.00154	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—TNF—gestational diabetes	6.73e-05	0.00151	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MTNR1B—gestational diabetes	6.72e-05	0.00151	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MTNR1B—gestational diabetes	6.58e-05	0.00147	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RBP4—gestational diabetes	6.55e-05	0.00147	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GLS2—gestational diabetes	6.5e-05	0.00146	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MTNR1B—gestational diabetes	6.47e-05	0.00145	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RBP4—gestational diabetes	6.41e-05	0.00144	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RBP4—gestational diabetes	6.31e-05	0.00141	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—NAMPT—gestational diabetes	6.2e-05	0.00139	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MTNR1B—gestational diabetes	6.18e-05	0.00138	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GCK—gestational diabetes	6.17e-05	0.00138	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GGCT—gestational diabetes	6.09e-05	0.00136	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.04e-05	0.00135	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RBP4—gestational diabetes	6.02e-05	0.00135	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GGCT—gestational diabetes	5.94e-05	0.00133	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.91e-05	0.00132	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MTNR1B—gestational diabetes	5.83e-05	0.00131	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.81e-05	0.0013	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—TNF—gestational diabetes	5.78e-05	0.00129	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MTNR1B—gestational diabetes	5.75e-05	0.00129	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RBP4—gestational diabetes	5.68e-05	0.00127	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RBP4—gestational diabetes	5.6e-05	0.00126	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GGCT—gestational diabetes	5.6e-05	0.00126	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LEPR—gestational diabetes	5.56e-05	0.00125	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GGCT—gestational diabetes	5.55e-05	0.00124	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LEPR—gestational diabetes	5.48e-05	0.00123	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LEPR—gestational diabetes	5.46e-05	0.00122	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GLS2—gestational diabetes	5.32e-05	0.00119	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—NAMPT—gestational diabetes	5.22e-05	0.00117	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GLS2—gestational diabetes	5.19e-05	0.00116	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GCK—gestational diabetes	5.19e-05	0.00116	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GLS2—gestational diabetes	4.89e-05	0.0011	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GLS2—gestational diabetes	4.85e-05	0.00109	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.76e-05	0.00107	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GGCT—gestational diabetes	4.74e-05	0.00106	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CYP19A1—gestational diabetes	4.51e-05	0.00101	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MTNR1B—gestational diabetes	4.4e-05	0.000986	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.34e-05	0.000972	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MTNR1B—gestational diabetes	4.33e-05	0.00097	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MTNR1B—gestational diabetes	4.32e-05	0.000968	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RBP4—gestational diabetes	4.29e-05	0.000961	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RBP4—gestational diabetes	4.22e-05	0.000945	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RBP4—gestational diabetes	4.21e-05	0.000943	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GLS2—gestational diabetes	4.15e-05	0.00093	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CYP19A1—gestational diabetes	3.79e-05	0.00085	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NAMPT—gestational diabetes	3.77e-05	0.000845	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GCK—gestational diabetes	3.75e-05	0.00084	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.71e-05	0.000831	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GGCT—gestational diabetes	3.66e-05	0.000821	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.6e-05	0.000807	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NAMPT—gestational diabetes	3.56e-05	0.000799	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GCK—gestational diabetes	3.54e-05	0.000794	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GLS2—gestational diabetes	3.2e-05	0.000717	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—LEP—gestational diabetes	2.98e-05	0.000669	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—LEP—gestational diabetes	2.92e-05	0.000655	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NAMPT—gestational diabetes	2.92e-05	0.000654	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GCK—gestational diabetes	2.9e-05	0.00065	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—LEP—gestational diabetes	2.88e-05	0.000645	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NAMPT—gestational diabetes	2.85e-05	0.000638	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GCK—gestational diabetes	2.83e-05	0.000634	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—LEP—gestational diabetes	2.74e-05	0.000615	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CYP19A1—gestational diabetes	2.74e-05	0.000614	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NAMPT—gestational diabetes	2.68e-05	0.000601	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GCK—gestational diabetes	2.67e-05	0.000597	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NAMPT—gestational diabetes	2.66e-05	0.000596	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GCK—gestational diabetes	2.64e-05	0.000592	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CYP19A1—gestational diabetes	2.59e-05	0.00058	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—LEP—gestational diabetes	2.59e-05	0.00058	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—LEP—gestational diabetes	2.55e-05	0.000572	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.27e-05	0.000509	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—FGF2—gestational diabetes	2.27e-05	0.000508	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GCK—gestational diabetes	2.26e-05	0.000506	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—FGF2—gestational diabetes	2.22e-05	0.000498	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—FGF2—gestational diabetes	2.18e-05	0.00049	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CYP19A1—gestational diabetes	2.12e-05	0.000475	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FGF2—gestational diabetes	2.08e-05	0.000467	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.07e-05	0.000464	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FGF2—gestational diabetes	1.97e-05	0.000441	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LEP—gestational diabetes	1.95e-05	0.000438	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.95e-05	0.000437	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FGF2—gestational diabetes	1.94e-05	0.000435	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.93e-05	0.000433	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LEP—gestational diabetes	1.92e-05	0.000431	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LEP—gestational diabetes	1.92e-05	0.00043	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.75e-05	0.000393	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GCK—gestational diabetes	1.74e-05	0.000391	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.65e-05	0.00037	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGF2—gestational diabetes	1.48e-05	0.000333	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGF2—gestational diabetes	1.46e-05	0.000327	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGF2—gestational diabetes	1.46e-05	0.000327	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.27e-05	0.000286	CbGpPWpGaD
